MXPA02005800A - Contortrostatina y metodos para su uso para prevenir metastasis y otras condiciones. - Google Patents

Contortrostatina y metodos para su uso para prevenir metastasis y otras condiciones.

Info

Publication number
MXPA02005800A
MXPA02005800A MXPA02005800A MXPA02005800A MXPA02005800A MX PA02005800 A MXPA02005800 A MX PA02005800A MX PA02005800 A MXPA02005800 A MX PA02005800A MX PA02005800 A MXPA02005800 A MX PA02005800A MX PA02005800 A MXPA02005800 A MX PA02005800A
Authority
MX
Mexico
Prior art keywords
contortrostatin
conditions
methods
preventing metastasis
metastasis
Prior art date
Application number
MXPA02005800A
Other languages
English (en)
Spanish (es)
Inventor
Francis S Markland Jr
Original Assignee
Univ Southern California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/460,295 external-priority patent/US6710030B1/en
Application filed by Univ Southern California filed Critical Univ Southern California
Publication of MXPA02005800A publication Critical patent/MXPA02005800A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
MXPA02005800A 1999-12-10 2000-12-09 Contortrostatina y metodos para su uso para prevenir metastasis y otras condiciones. MXPA02005800A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/460,295 US6710030B1 (en) 1993-10-22 1999-12-10 Contortrostain (CN) and methods for its use in preventing metastasis and other conditions
US59155200A 2000-06-08 2000-06-08
PCT/US2000/033367 WO2001041791A1 (en) 1999-12-10 2000-12-09 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions

Publications (1)

Publication Number Publication Date
MXPA02005800A true MXPA02005800A (es) 2003-10-14

Family

ID=27039626

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02005800A MXPA02005800A (es) 1999-12-10 2000-12-09 Contortrostatina y metodos para su uso para prevenir metastasis y otras condiciones.

Country Status (7)

Country Link
EP (1) EP1235586A4 (de)
JP (1) JP2004500357A (de)
AU (1) AU2077001A (de)
BR (1) BR0016488A (de)
CA (1) CA2393463A1 (de)
MX (1) MXPA02005800A (de)
WO (1) WO2001041791A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7754850B2 (en) 2005-02-11 2010-07-13 University Of Southern California Chimeric disintegrin domain

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA889415B (en) * 1987-12-18 1989-09-27 Chiron Corp Compositions and method for recombinant production of crotalidus venum fibrolase
US5182260A (en) * 1989-01-27 1993-01-26 Biogen, Inc. Dna sequences encoding snake venom inhibitors of platelet activation processes for producing those inhibitors and compositions using them
US5731288A (en) * 1993-10-22 1998-03-24 University Of Southern California Compositions containing contortrostatin and methods for the use thereof
KR0142606B1 (ko) * 1995-07-05 1998-07-01 허영섭 혈소판 응집 억제 펩타이드 및 그의 제조방법
BR9914466A (pt) * 1998-09-29 2001-10-16 Univ Southern California "contortrostatina (cn) e métodos para seu uso na prevenção da metástase e outras condições"

Also Published As

Publication number Publication date
WO2001041791A1 (en) 2001-06-14
JP2004500357A (ja) 2004-01-08
WO2001041791A9 (en) 2002-07-04
CA2393463A1 (en) 2001-06-14
BR0016488A (pt) 2003-06-24
AU2077001A (en) 2001-06-18
EP1235586A4 (de) 2005-08-03
EP1235586A1 (de) 2002-09-04

Similar Documents

Publication Publication Date Title
HU9903361D0 (en) Filter-device with collecting-vessel and with heating-device
DE69927412D1 (en) Phosphitadditive in polyolefinen
IL147382A0 (en) Running and testing applications
ZA991951B (en) Compound and its use.
ZA200203316B (en) New use and novel n-azabicyclo-amide derivatives.
ZA991946B (en) Pyrazolopyrimidines and pyrazolotriazines.
GB9819795D0 (en) Plug and plug set for use in wellbore
HK1019774A1 (en) Etching composition and use thereof.
ZA991845B (en) Catalyst and use thereof.
IL136534A0 (en) Magnetic bearing and its use
IL139011A0 (en) Gene coding for helimicine and use thereof
EP1210084A4 (de) Pyridomorphinane, thienomorphinane und deren verwendung
HUP0103473A3 (en) Phosphoglycolipid and methods for its use
GB9919689D0 (en) Back-lighting arrangement and the like
IL128193A0 (en) Rhamnosyl-transferase gene and uses thereof
GB2370233B (en) Apparatus for use in behaviour modification and the like
EP1117761A4 (de) Für MNR2 kodierendes Gen und Verfahren
GB9813781D0 (en) Improvements in security documents and substrates therefor
IL145220A0 (en) Stabilized composition based on pyridinyl-sulfinyl-benzimidazoles and process
MXPA02005800A (es) Contortrostatina y metodos para su uso para prevenir metastasis y otras condiciones.
IL145711A0 (en) Thrombospondin-2 and uses thereof
GB0014643D0 (en) Methods and assemblies
GB2352003B (en) Polymer and metal integrated latch
HK1026015A1 (en) Supporting device and the holding-profile therefor.
HUP0105189A3 (en) Organoprotective solutions and their use